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A B S T R A C T
Objectives: To evaluate outcomes and quality of life in patients operated transvaginally with an original
mesh shape for uterus-sparing prolapse surgery and to demonstrate the safety and efficacy of the
technique.
Study design: We prospectively evaluated 66 postmenopausal patients (POP-Q Stage III: 32, IV: 34)
operated between May 2008 and December 2013. We used wide weave polypropylene monofilament
mesh that functions as a hammock anchored posteriorly to sacrospinous ligaments, its anterior wings
exit the pelvis through the obturatory membrane.
Follow-up was scheduled at 3-, 12- months and in May 2016. Prolapse-Quality of Life Questionnaire (P-
QoL) was administered preoperatively, at 12 months and in May 2016. The chi square and Wilcoxon test
were used for statistical analysis.
Results: Mean follow-up was 5.6 (SD: 1.6, Range: 1.1–8.1) years. The overall success rate (POP-Q  2) was
92.5% at 12 months and 84.4% at May 2016, these data remained stable over time (p > 0.05). Early
complications occurred in 2 (3%) patients, late in 5 (7.8%) of which mesh extrusion in 4 (6.3%). Data from
P-QoL showed significant improvement between preoperative and postoperative data (P < 0.01 for all
domains) and they remained stable with time (p > 0.05). De-novo dyspareunia was 17.6% at 12 months
and 10.3% at May 2016.
Conclusions: The low rate and grade of complications demonstrates the safety of the procedure, which
offers stable anatomical correction with significant improvement in QoL.
© 2018 Elsevier B.V. All rights reserved.
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Patients diagnosed with high-grade uterine prolapse, either
III–IV according to the Pelvic Organ Prolapse Staging System
(POP-Q), often require surgical treatment to correct their anatomo-
functional defect. There are many surgical options, such as vaginal
hysterectomy combined with native tissue repair including
uterosacral or sacrospinous ligament suspension. Another option
is to use synthetic materials in the repair or apical suspension.
Further still, uterus-sparing surgery may be performed, again with
various combinations and options for repair and suspension using
native tissue and/or synthetic materials [1]. Recently the U.S. Food
and Drug Administration (FDA) increased data requirements for
the use of surgical meshes for pelvic organ prolapse (POP) repair
through the vagina, and such meshes were re-categorized as class* Corresponding author at: Clinica Urologica II, Azienda Ospedaliera Careggi,
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0301-2115/© 2018 Elsevier B.V. All rights reserved.III instead of class II which made them high-risk devices [2]. The
FDA policy decision affected trans-vaginal procedures employing
synthetic meshes, even outside the USA. Yet, is it realistic that
many studies describing the anatomical rationale for the use of a
mesh in POP and the thousands of patients who have successfully
undergone this treatment have all been an error?
Our two decades’ experience with mesh surgery prompts a
critique of the FDA reclassification. We began to repair POP with
mesh in the 1990s [3], and have persisted to the present because
our results have been consistently more than satisfactory. In fact,
we report only a modest rate of minor complications.
In our center we adopt two original vaginal techniques, one for
single prolapse of the anterior segment (cystocele) [3], and the
other for prolapse of the middle segment (cystocele and uterus or
vaginal vault) [4]. For each defect we use soft, macroporous, wide
weave polypropylene monofilament mesh (type 1 according to the
Amid classification [5]) from the commercial market. Specifically,
from 2006 we selected Gynemesh (Ethicon) and used it until 2013
though in 2012 it had gone off the market. Now we use Restorelle1
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two types of prolapse. The novelties of our procedure are the shape
of the mesh and the method of anchoring it to the uterus.
The aims of the current study were to evaluate outcomes and
patient satisfaction in cases of uterine prolapse (POP-Q stage III/IV)
treated with vaginal mesh, while preserving the uterus.
The primary objective of the study was to assess the
effectiveness of anatomical correction, safety and complications.
The secondary objective was to evaluate the resolution of
symptoms and the effect on quality of life (QoL).
Study design
We performed a prospective observational study between May
2008 and December 2013. In average, at our center 20 patients
receive procedure for anterior prolapse yearly, while 10–12
patients receive operation for POP yearly; 2–3 patients are referred
to the gynecology department either for patient’s preference or for
underlying gynecological pathologies such as uterine fibromatosis.Fig. 1. The Rationale for the Shape of the Mesh.
The estimated area of the central body of the mesh (excluded wings) is 4500 mm2 it is s
drawing the mesh tautly without creases, which reduces the risk of extrusions. The shap
placed in back of the central aperture (B) where it is encircled and sustained, like the ca
created on either side of the cervix. These halves, joined under the cervix with two s
immediately under the cervix but not so strict as to create tissue lesions. The diameter 
through it. The mesh fastening: two front wings exit the pelvis passing through the ips
urethropelvic ligaments). Two rear wings are fixed to the ipsilateral sacro-spinous ligam
Finally, the mesh, taught between the anchoring points forms a new stable floor for the o
pulled tautly between the pubis and the sacrum.We enrolled 66 patients with high grade anterior and apical
descensus, i.e. point Aa, Ba and point C at stage >2 according to the
POP-Q. Absolute exclusion criteria were: hypersensitivity to
synthetic materials, previous hysterectomy or POP surgery,
postmenopausal bleeding, abnormal cervical smears, uterine
disease, an adnexal masses, or BMI >30 kg/m2.
For each patient the utility of a mesh implant was carefully
evaluated. Informed consent, clarifying the novelty of the
technique, the possibility of failure, and correlative risks was
obtained from all participants.
The characteristics of the mesh are shown in Fig. 1. The mesh
corrects the weakened fascial support that led to the POP by
recreating the two levels of support for the bladder and the uterus
theorized by DeLancey [6]. The dimensions conform to average
pelvic diameters.
Preoperative patient assessment consisted of history, pelvic
examination using POP-Q, supine stress test with prolapse
reduced, to detect occult stress incontinence that was measured
using the Ingelman-Sundberg scale [7]. Urodynamic evaluationmaller than the area of Prolift (6770 mm2 excluding the wings). The size facilitates
e: the cystocele lies in the anterior portion of the mesh (A). The neck of the uterus is
rdinal ligaments, by the two posterior halves, as they are passed through a tunnel
titches, make a surface that supports the enterocele (C). The stitches are placed
of the hole in the mesh is smaller than that of cervix to avoid that the uterus slide
ilateral obturatory foramen (they substitute the support of the pubo-urethral and
ent with a single stitch (they substitute the support of the sacro-uterine ligaments).
rgans lying above it. In orthostatism the mesh in the pelvis is similar to a hammock
G. Nicita et al. / European Journal of Obstetrics & Gynecology and Reproductive Biology 222 (2018) 57–63 59included uroflowmetry, post-void residual volume, filling cystom-
etry and pressure/flow study with and without prolapse reduction
using a pessary, following the InternationaI Continence Society
(ICS) standard [8]. All patients were asked to compile the Italian
version of the Prolapse-Quality of Life Questionnaire (P-QoL) [9].
All patients were post-menopausal. Baseline patients’ charac-
teristics, LUTS and pre-operative urodynamic data are listed in
Table 1.
Surgical technique
All patients, after general anaesthesia, were placed in the dorsal
lithotomy position and a 16F bladder catheter was introduced. A
Scott retractor was positioned and a midline longitudinal anterior
colpotomy was made from the bladder neck to the cervix. The
pubo-cervical fascia, that lies over the cystocele was exposed up to
its insertion on the ischio-pubic branch at both the right and the
left sides. Each front wing of the prosthesis, connected to an inside-
out transobturator handle, was passed through the obturator
membrane and the skin, and it was pulled out until the mesh
reached the bladder. A midline posterior colpotomy was made
from the fornix to the end of the enterocele, and by using a Kelly-
type curved forceps, Fig. 2, a passage between the posterior and
anterior vaginal segments was pierced as close as possible to the
apex of the cervix. Each half of the mesh was passed through the
ipsilateral passage until the cervix was placed at the center of the
aperture in the mesh, to fasten it to the prosthesis. Two sutures
joined the medial edges of the halves of the mesh to create a
support plane for the enterocele. The rear wings were fixed to the
ipsilateral sacrospinous ligaments with a stitch using the Capio1
instrument and the uterus was pushed up into its correct position.
Eventually the colpotomies were sutured. Figs. 3 and 4 show the
location of the mesh in the pelvis. Patients with stress urinary
incontinence (SUI) received a single incision transvaginal sling. All
procedures were performed by an expert surgeon (G.N.).
Postoperative follow-up and data analysis
Post-operative assessment was planned at 1 (functional data
not considered for the study purposes), 3 and 12 months. All
patients were offered a visit free of charge in May 2016. Each time
the visit included a pelvic examination. P-QoL questionnaires were
distributed at 12 months and in May 2016. Postoperative
urodynamic analysis was performed only when needed.
We defined objective anatomical cure at POP-Q stage less than
2, satisfactory cure at POP-Q stage equal to 2, while unsuccessful
repair was POP-Q stages of 3 or 4.
We used the Clavien-Dindo grade for surgical complications
and the IUGA/ICS classification for mesh-related ones [10,11].Table 1
Baseline patients’ characteristics, lower urinary tract symptoms (LUTS) and pre-
operative urodynamic data.
Mean age (SD, Range), years 69.7 (7.7, 50–87)
Mean BMI (SD), kg/m2 24.9 (5.2)
Median parity (IQR), n 2 (1–2)
Filling phase LUTS, n (%) 28 (42.4)
Voiding phase LUTS, n (%) 15 (22.7)
Mean Voided volume (SD), ml 348.75 (98.41)
Mean Maximal capacity (SD), ml 375.74 (75.48)
Mean Q max (SD), ml/min 18.07 (7.12)
Mean Q average (SD), ml/min 11.4 (4.94)
Mean PVR (SD), ml 44.81 (69.07)
Mean MUCP (SD), cmH2O 54.26 (20.12)
SD: standard deviation; IQR: interquartile range; PVR: post-void residual; MUCP:
Maximum urethral closure pressure.For statistical analysis, the chi-square test was used to compare
data from POP-Q at different times, the Wilcoxon test was used for
comparing the differences in P-QoL. Results were considered
statistically significant when p < 0.05.
Methods, definitions and units conform to the standards
recommended by the ICS [12].
No financial assistance was received from any company in the
design or execution of this study.
Results
All patients were alive at 3 and 12 months follow-up. In May
2016, 64 (97%) patients were examined, 2 (3%) were lost at follow-
up. The mean follow-up time was 5.6 (SD: 1.6, Range: 1.1–8.1)
years. 21 (32%) patients with stress incontinence received
contemporary SUI surgery using a single incision transvaginal
sling. Mean operating time was 82  20 min. Bladder catheter was
removed on the third postoperative day. Median hospital stay was
3 (Range 3–5) days. The 30-day Clavien complication rate was 3%,
due in both cases to grade III A complications: a pelvic hematoma
in one patient and urinary retention requiring one week of self-
catheterization in another who underwent concomitant SUI
surgery. Late complications occurred in a total of 5 (7.8%) patients;
specifically: 1 (1.5%) grade II de novo urge incontinence (without
urodynamic detrusor overactivity) treated with antimuscarinics
and, 4 (6.3%) grade III A small vaginal mesh extrusion (IUGA/ICS
classification 1, T3, S1, a in all cases) treated with vaginal removal of
the exposed portion of the mesh as an outpatient that did not
require even local anaesthesia. No patient referred de novo
subjective complaints related to bowel function.
Concerning the primary objective, the overall success rate (POP-
Q  2) was 92.5% at 12 months and 84.4% at May 2016. We
registered 3 (4,5%) stage IV cases at 3 months. We considered these
cases as failures, not complications. In our experiences early
recurrence of the prolapse is probably due to a technical mistake,
loosening of the stitches, breakage of the mesh or of the anchorage
structure. At 12 months after surgery 42 (63.6%) patients were
cured: (9 (13.6%) stage 0, 33 (50%) stage I) and 19 (28.9%) presented
satisfactory prolapse cure. 5 (7.6%) were considered unsuccessful
(2 (3%) stage III and 3 (4.5%) stage IV). These values tended to
remain stable over time, Table 2, in fact no statistical difference
was observed comparing postoperative data between 3 and 12
months (p > 0.05) nor between 12 months and data collected in
May 2016 (p > 0.05). In May 2016, 10 (15.6%) patients of 64
compliant with follow-up, presented unsuccessful repair (2 of
them underwent hysterectomy in another hospital while 5 stage
III, 3 stage IV did not receive other procedures), rendering an
overall success rate of 84.4%.
Regarding the secondary objective, a statistical difference
emerged between data from preoperative P-QoL questionnaires
and from postoperative questioning (p < 0.01 for all domains).
However, a comparison of follow-up data for patients in May 2016
with their 12 months postoperative data showed no statistical
difference (p > 0.05 for all domains), Fig. 5. No patients developed
de novo SUI. Concerning the personal relationships domain of the
P-QoL questionnaire, 32 patients were sexually inactive, not for
reasons attributable to POP (either for age, lacking of partner, ecc.).
Among the remaining 34 patients, at 12 months 11 (32.4%) referred
dyspareunia, 5 of them reported such symptom already before
surgery; thus the de-novo dyspareunia rate was 17.6% (6 patients)
at 12 months. At May 2016, 7 (20.6%) out of 29 sexually active
patients complained of dyspareunia, 4 of them were already
affected before surgery. The de-novo dyspareunia rate at May 2016
was 10.3%. At examination, the patients with de-novo dyspareunia
presented vaginal dryness and/or vaginal rigidity.
Fig. 2. Passage of the mesh between the posterior and anterior vaginal segments.
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Surgery aimed at pelvic floor reconstruction allows for different
approaches: vaginal, open abdominal, laparoscopic or robotic.
Operative time is generally shorter when the vaginal approach is
adopted, as are hospital stay and recovery time [13,14]. Biocom-
patible or synthetic materials can be employed in pelvic floor
reconstructive surgery, the debate about the best option is ongoing
[15,16]. Synthetic meshes have been highly criticized in recentyears, but the use of mesh in pelvic floor surgery is the
reconstructive technique that best corresponds to anatomy
because the shape of the mesh correctly reproduces the human
pelvic floor. Moreover literature has underlined the uterus sparing
technique as a viable option for the surgical management of
uterine prolapse, because it is best at retaining the original
anatomy and statics of the pelvic floor [17].
The results of our study confirm the effectiveness of our uterus-
sparing technique for the correction of high-grade anterior and
Fig. 3. Mesh in the pelvis. Upper view.
Fig. 4. Mesh in the pelvis. Schematic lateral view.
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is comparable to data reported in the literature for different
procedures [1,18,19]. The length of our follow-up period suggeststhat results are stable over time. We have also observed a
significant improvement in prolapse symptoms and quality of life.
Our positive results are due to the logic of the mesh, its shape, and
Table 2
Data from POP-Q at different follow-up times.
Preoperative, n = 66 3 months postoperative, n = 66 12 months postoperative, n = 66 May 2016a, n = 64b
Stage 0, n (%) – 10 (15.1) 9 (13.6) 7 (11.3)
Stage I, n (%) – 32 (48.5) 33 (50) 31 (50)
Stage II, n (%) – 19 (28.9) 19 (28.9) 16 (25.8)
Stage III, n (%) 32 (48.5) 2 (3) 2 (3) 5 (8.1)
Stage IV, n (%) 34 (51.5) 3 (4.5) 3 (4.5) 3 (4.8)
a 2 patients were lost at May 2016 follow-up: one who had Stage IV POPQ at 12 months and another who had Stage II at 12 months.
b 2 patients underwent hysterectomy in another hospital, after 2 and 4 years of surgery respectively and have been considered as unsuccesful repair.
Fig. 5. Data from P  QoL.
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posed between mesh and bladder acts as a buffer avoiding direct
contact between bladder and mesh. We prefer to interpose the
fascia between the mesh and the bladder to add protection to this
organ. The rare vesical erosions are much more serious than those
of the vagina, which are easily repaired.
Moreover when the pubocervical fascia is isolated from the
bladder and left attached to the vaginal wall, the weak site (where
erosions often occurred), is exactly where the walls and fascia are
cut and then sutured. The procedure counteracts the causes of
prolapse by recreating a new pelvic floor support, and implies no
organ removal. The mesh, ultimately lies on a plane with the
posterior part higher than the anterior one, thus it reestablishes
the anatomical floor of the levator ani muscle, it is placed tension-
free in the pelvis, avoiding wrinkles that are the primary cause of
vaginal erosions. The rectum, located between the posterior mesh
wings, maintains its anatomical position and is under no pressure
from the mesh.
Surgical correction of uterovaginal prolapse traditionally
involves hysterectomy even if the uterus is believed to be passive
in the disease. Removal of the uterus disrupts the equilibrium
between the interactions of the pelvic organs regarding organ
descent [20]. Additionally, hysterectomy cures the main “prolapse
symptom”, but it is less efficient in treating the cause, which is
weakened support from musculofascial structures [21]. The void
created by hysterectomy can cause a weakened area through which
vaginal segments may prolapse [22].
Over the past few decades, uterus-sparing surgery, which we
were among the first to practice [3], has become more popular
worldwide and there is growing consensus that the uterus can be
preserved in pelvic reconstructive surgery in appropriate patients[23,24]. In fact, when hysterectomy is associated with POP surgery,
operation time grows, blood loss is greater, and there are generally
more complications, above all when a mesh is inserted by a vaginal
approach [24]. Moreover, there is debate about whether anatomi-
cal modifications induced by hysterectomy implicate sexuality
[25].
The use of meshes in treating POP was prompted by their use in
incontinence surgery: the ease of implementation and positive
results obtained suggested that meshes might yield similar results
in POP surgery. Many products appeared on the market without
appropriate clinical trials due to their simple production technol-
ogy and high profit margins [26]. Furthermore, surgeons with little
experience in this field were attracted by the apparent simplicity of
use offered by commercial kits, some of them were difficult to use
due to dimensions and anchoring technique. All these factors are
responsible for a great amount of complications in patients
receiving trans-vaginal procedures, leading to lawsuits failed
against surgeons and industries. These circumstances led the FDA
to require strict pre-clinical validation of meshes, and to a re-
classification of these devices. Now they must meet stricter
standards of efficacy for resolving the anatomical problem they
intend to correct before they reach the market. In addition, a
focused training which, however, has not yet been standardized,
should be required. Indeed surgical experience is of pivotal
importance [1,27]. Kelly et al. found the risk of complications to be
lower for surgeons performing 14 or more procedures per year
[27]. We agree with the FDA restrictions on the use of meshes for
POP, but we take issue on their designation as high risk devices [2].
A specific risk resulting from the use of mesh in pelvic floor
reconstruction surgery is mesh exposure [26]. The modern soft
polypropylene large weave meshes reduced this risk as our low
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such as dyspareunia and pelvic floor pain may also result from
biocompatible materials [28]. Dyspareunia in post-menopausal
women is not uncommon even without POP, its entity is usually
difficult to evaluate. The rate of de-novo dyspareunia among our
sexually active patients was 10.3%, which is comparable to values
reported by other authors [15,29], none of our patients referred
pelvic pain attributable to sacrospinous ligaments stitches.
Despite criticism of synthetic materials, recent Cochrane
reviews, albeit with metanalyses biases, affirmed that the use of
vaginal meshes lowers the risk of prolapse symptoms and of
recurrent anterior vaginal prolapse when compared to biocom-
patible tissue and fascial repair [26,30]. Our results are in keeping
with those findings, confirming stable success rate over the long-
term.
The limits of this study are: its monocentric prospective
observational structure with a limited number of patients and its
lack of a comparison with other techniques, such as hysterectomy
and fascial repair. Uterus sparing surgery does raise questions of
most suitable approach, whether vaginal, abdominal, or laparo-
scopic.
In conclusion, our technique is feasible for a urogynecologist of
average experience trained by taking a hand in a few procedures.
The low rate of complications demonstrates the safety both of the
material and the procedure, which offers a stable and notable
anatomical correction of prolapse with improvements in patient
QoL. This finding warrants prospective evaluation in clinical trials.
More experience is needed to determine which approach is best for
prolapse surgery.
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